HOME › DRUGS › DUPILUMAB
ACTIVE SUBSTANCE / INN

DUPILUMAB

Brand name(s): Dupixent, DUPIXENT
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA761055
Dermatitis, Atopic;Prurigo;Esophageal Diseases;Asthma;Sinusi…
ACTIVE SUBSTANCE
Dupilumab
REGULATORS
FDA · EMA
SPONSORS / MAH
Sanofi Winthrop Industrie, REGENERON PHARMACEUTICALS
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DUPIXENTBLA761055REGENERON PHARMACEUTICALSPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
DupixentSanofi Winthrop IndustrieAuthorised26/09/2017Dermatitis, Atopic;Prurigo;Esophageal Diseases;Asthma;Sinusitis

FULL INTELLIGENCE ON DUPILUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →